Human MTAP/BDMF/c86fus ORF/cDNA clone-Lentivirus plasmid (NM_002451)
Cat. No.: pGMLP000994
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human MTAP/BDMF/c86fus Lentiviral expression plasmid for MTAP lentivirus packaging, MTAP lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
MTAP/BDMF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000994 |
| Gene Name | MTAP |
| Accession Number | NM_002451 |
| Gene ID | 4507 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 852 bp |
| Gene Alias | BDMF,c86fus,DMSFH,DMSMFH,HEL-249,LGMBF,MSAP |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCCTCTGGCACCACCACCACCGCCGTGAAGATTGGAATAATTGGTGGAACAGGCCTGGATGATCCAGAAATTTTAGAAGGAAGAACTGAAAAATATGTGGATACTCCATTTGGCAAGCCATCTGATGCCTTAATTTTGGGGAAGATAAAAAATGTTGATTGCGTCCTCCTTGCAAGGCATGGAAGGCAGCACACCATCATGCCTTCAAAGGTCAACTACCAGGCGAACATCTGGGCTTTGAAGGAAGAGGGCTGTACACATGTCATAGTGACCACAGCTTGTGGCTCCTTGAGGGAGGAGATTCAGCCCGGCGATATTGTCATTATTGATCAGTTCATTGACAGGACCACTATGAGACCTCAGTCCTTCTATGATGGAAGTCATTCTTGTGCCAGAGGAGTGTGCCATATTCCAATGGCTGAGCCGTTTTGCCCCAAAACGAGAGAGGTTCTTATAGAGACTGCTAAGAAGCTAGGACTCCGGTGCCACTCAAAGGGGACAATGGTCACAATCGAGGGACCTCGTTTTAGCTCCCGGGCAGAAAGCTTCATGTTCCGCACCTGGGGGGCGGATGTTATCAACATGACCACAGTTCCAGAGGTGGTTCTTGCTAAGGAGGCTGGAATTTGTTACGCAAGTATCGCCATGGCGACAGATTATGACTGCTGGAAGGAGCACGAGGAAGCAGTTTCGGTGGACCGGGTCTTAAAGACCCTGAAAGAAAACGCTAATAAAGCCAAAAGCTTACTGCTCACTACCATACCTCAGATAGGGTCCACAGAATGGTCAGAAACCCTCCATAACCTGAAGAATATGGCCCAGTTTTCTGTTTTATTACCAAGACATTAA |
| ORF Protein Sequence | MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T40787-Ab | Anti-MTAP monoclonal antibody |
| Target Antigen | GM-Tg-g-T40787-Ag | MTAP protein |
| ORF Viral Vector | pGMLP000994 | Human MTAP Lentivirus plasmid |
| ORF Viral Vector | vGMLP000994 | Human MTAP Lentivirus particle |
Target information
| Target ID | GM-T40787 |
| Target Name | MTAP |
|
Gene Group Identifier (Target Gene ID in Homo species) |
4507 |
| Gene ID |
101088961 (Felis catus), 298227 (Rattus norvegicus), 4507 (Homo sapiens), 474729 (Canis lupus familiaris) 66902 (Mus musculus), 709020 (Macaca mulatta), 782907 (Bos taurus) |
| Gene Symbols & Synonyms | MTAP,Mtap,Cc1-6,BDMF,MSAP,DMSFH,LGMBF,DMSMFH,c86fus,HEL-249,1300019I21Rik,MTAPase |
| Target Alternative Names | 1300019I21Rik,5'-methylthioadenosine phosphorylase (MTA phosphorylase,BDMF,Cc1-6,DMSFH,DMSMFH,HEL-249,LGMBF,MSAP,MTAP,MTAPase,MTAPase),Mtap,S-methyl-5'-thioadenosine phosphorylase,c86fus |
| Uniprot Accession |
F6RQL9,Q13126,Q9CQ65
Additional SwissProt Accessions: Q13126,Q9CQ65,F6RQL9 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | Metabolic pathways |
| Gene Ensembl | ENSG00000099810, ENSCAFG00845016288, ENSMUSG00000062937, ENSMMUG00000001137, ENSBTAG00000025929 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


